did they sign an "exclusive" with Novartis? RHT has to be more...

First 15 Last

Share
Profile

Follow
RE7LEX

139 Posts.

02/02/17

10:47

Post #: 22312283
Share

Originally posted by hoofa ↑

If you take out the prop of 2 million at .019c - you have investors to the tune of $20k interested in this company.

That is after RHT has been operating for over a decade of operation in the high profile market of providing medical technologies.

The revenue in 2009 was $2,390,961

The revenue in 2016 was $2,596,624

So in nearly 8 years the company has increased its revenue by $205k

...............so for all the $800,000 spend on marketing last year, the 13 people composing Board and management along with cap raising this is the result. Going on the figures for the first half of this year the annual revenue will see little change in 8 years.

imo the revenue is coming from one customer Novatis and the arrangement they have with RHT for using Ferriscan in their testing procedures. In 2010 they signed an agreement with Novartis and it would seem that this company controls the destiny of RHT. Might be wrong but without them RHT would be non existent.
Hence imo why there is no detail on revenue and where it comes from. imo it comes from one customer and they have RHT by the cods. They know that Novatis is essential to their survival. Novartis stitched them up with a watertight agreement on Ferriscan and the rest is history.

My opinions are only that, but I can only deduce my comments from the information available in reports and the fact that RHT seems to be hamstrung in its developments.

It basically has one customer keeping it as a viable business........what else can you assume...they will not divulge how their revenue is sourced.

Any other opinions?

Expand

did they sign an "exclusive" with Novartis? RHT has to be more transparent and more accountable

RHT Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply